Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 151
Filtrar
1.
Adv Neonatal Care ; 20(3): 216-222, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-31922972

RESUMO

BACKGROUND: While women in the Deep South area of the United States have higher rates of maternal and infant mortality, palliative and supportive care programs are lacking. Additionally, few studies have detailed referral triggers that are specific to the mother, infant, or pregnancy for inclusion in perinatal and neonatal palliative and supportive care programs. PURPOSE: The purpose of this retrospective, descriptive study was to examine the sociodemographic factors and referral triggers for perinatal-neonatal palliative and supportive care services for women enrolled in a newly developed perinatal-neonatal palliative and supportive care program. METHODS: Data were collected from medical records of 135 women enrolled in the program. Triggers for referral to the program were classified as fetal, maternal, or prenatal complications. RESULTS: A diverse sample of women were enrolled in the program. Most infants survived to birth and discharge from the hospital. Two-thirds of referrals were related to infant complications and 34% were for multiple complications (fetal, maternal, and/or prenatal). Triggers for referral to the program were not related to sociodemographic characteristics of women. IMPLICATIONS FOR PRACTICE: A comprehensive list of triggers that include maternal and prenatal complications, in addition to infant complications, may ensure at-risk women and infants, are enrolled in perinatal-neonatal palliative and supportive care programs early in pregnancy, regardless of sociodemographic factors. IMPLICATIONS FOR RESEARCH: Prospective research on the effectiveness of perinatal-neonatal palliative and supportive care programs in diverse populations of women is needed. This includes the examination of family health outcomes and provider perspectives.


Assuntos
Cuidados Paliativos na Terminalidade da Vida , Cuidados Paliativos , Assistência Perinatal/métodos , Sistemas de Apoio Psicossocial , Adulto , Feminino , Necessidades e Demandas de Serviços de Saúde , Cuidados Paliativos na Terminalidade da Vida/métodos , Cuidados Paliativos na Terminalidade da Vida/organização & administração , Humanos , Lactente , Cuidado do Lactente/métodos , Mortalidade Infantil , Recém-Nascido , Mortalidade Materna , Cuidados Paliativos/métodos , Cuidados Paliativos/organização & administração , Cuidados Paliativos/psicologia , Gravidez , Estudos Retrospectivos , Serviços de Saúde Rural/organização & administração , Serviços de Saúde Rural/normas , Estados Unidos/epidemiologia
2.
Neonatal Netw ; 39(1): 24-28, 2020 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-31919290

RESUMO

When an expectant mother hears the news that her infant has a fetal anomaly, she may feel unsure of the future. A RN recognized the needs of women (and their families) expecting infants with critical fetal diagnoses and reached out to help them through their journey-through the pregnancy, delivery, and beyond. The act of walking alongside the mothers through their experience has grown into a formal program at a specialized children's and womens' hospital in the southeastern United States. This article describes the purpose of the program, how the program came into existence, and what services the program provides to this special population. The program continues to evolve, and the team members have worked with over 169 mothers to date.


Assuntos
Anormalidades Congênitas/diagnóstico , Doenças Fetais/diagnóstico , Mães/psicologia , Equipe de Assistência ao Paciente/organização & administração , Cuidado Pré-Natal/métodos , Diagnóstico Pré-Natal/psicologia , Anormalidades Congênitas/psicologia , Feminino , Humanos , Recém-Nascido , Relações Mãe-Filho , Relações Médico-Paciente , Gravidez , Diagnóstico Pré-Natal/métodos , Desenvolvimento de Programas , Avaliação de Programas e Projetos de Saúde , Revelação da Verdade , Estados Unidos
3.
Placenta ; 69: 50-56, 2018 09.
Artigo em Inglês | MEDLINE | ID: mdl-30213484

RESUMO

INTRODUCTION: The Liver X Receptors (LXRs) drive the transcriptional response to excess intracellular cholesterol. Oxysterols, the products of cholesterol oxidation, are activating ligands for LXR that can accumulate under conditions of oxidative stress and disrupt cholesterol homeostasis. While activation of LXR inhibits trophoblast differentiation, the impact of LXR on trophoblast physiology or cholesterol homeostasis is incompletely understood. We sought to determine if the effects of LXR activation can be ameliorated through modification of cholesterol bioavailability or inhibition of LXR-driven cholesterol efflux in trophoblasts. METHODS: We measured the effect of oxysterol exposure on BeWo cells and primary human trophoblasts (PHT cells) cultured in lipoprotein-deficient medium. We also measured the effect of the synthetic, LXR-specific ligand T0901317 on PHT cell differentiation and survival. Finally, we silenced the ATP-binding cassette transporter A1 (ABCA1), a transcriptional target of LXR that drives cholesterol efflux, to determine if inhibition of cholesterol efflux could block the effects of T0901317. RESULTS: Oxysterols inhibited BeWo survival and PHT cell differentiation, and these effects were blocked by cholesterol supplementation. T0901317 also inhibited PHT cell differentiation, and this effect was similarly blocked by cholesterol. Unlike cholesterol however, ABCA1 silencing did not modify the effect of T0901317 on PHT cell differentiation. DISCUSSION: Oxysterols and LXR inhibit trophoblast survival and differentiation exclusively in conditions of cholesterol scarcity. These findings underscore the importance of cholesterol homeostasis in the maintenance of placental function and suggest that pathways regulating cholesterol homeostasis may represent therapeutic targets to mitigate harmful sequelae of placental injury.


Assuntos
Transportador 1 de Cassete de Ligação de ATP/metabolismo , Diferenciação Celular/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Receptores X do Fígado/agonistas , Oxisteróis/farmacologia , Trofoblastos/efeitos dos fármacos , Transportador 1 de Cassete de Ligação de ATP/genética , Diferenciação Celular/fisiologia , Linhagem Celular , Sobrevivência Celular/fisiologia , Colesterol/metabolismo , Feminino , Humanos , Hidrocarbonetos Fluorados/farmacologia , Placenta/citologia , Placenta/efeitos dos fármacos , Placenta/metabolismo , Gravidez , Sulfonamidas/farmacologia , Trofoblastos/citologia , Trofoblastos/metabolismo
4.
Nat Commun ; 9(1): 2368, 2018 06 18.
Artigo em Inglês | MEDLINE | ID: mdl-29915250

RESUMO

Complex tissue-specific and cell-specific signaling by the estrogen receptor (ER) frequently leads to the development of resistance to endocrine therapy for breast cancer. Pure ER antagonists, which completely lack tissue-specific agonist activity, hold promise for preventing and treating endocrine resistance, however an absence of structural information hinders the development of novel candidates. Here we synthesize a small panel of benzopyrans with variable side chains to identify pure antiestrogens in a uterotrophic assay. We identify OP-1074 as a pure antiestrogen and a selective ER degrader (PA-SERD) that is efficacious in shrinking tumors in a tamoxifen-resistant xenograft model. Biochemical and crystal structure analyses reveal a structure activity relationship implicating the importance of a stereospecific methyl on the pyrrolidine side chain of OP-1074, particularly on helix 12.


Assuntos
Antineoplásicos/farmacologia , Benzopiranos/farmacologia , Antagonistas de Estrogênios/farmacologia , Neoplasias Mamárias Experimentais/tratamento farmacológico , Pirrolidinas/farmacologia , Fosfatase Alcalina/análise , Animais , Antineoplásicos/análise , Antineoplásicos/síntese química , Antineoplásicos/uso terapêutico , Benzopiranos/síntese química , Benzopiranos/química , Benzopiranos/uso terapêutico , Proliferação de Células/efeitos dos fármacos , Antagonistas de Estrogênios/análise , Antagonistas de Estrogênios/síntese química , Antagonistas de Estrogênios/uso terapêutico , Receptor alfa de Estrogênio/efeitos dos fármacos , Feminino , Humanos , Células MCF-7 , Camundongos Endogâmicos BALB C , Camundongos Nus , Conformação Proteica em alfa-Hélice/efeitos dos fármacos , Pirrolidinas/química , Pirrolidinas/uso terapêutico , Moduladores Seletivos de Receptor Estrogênico/análise , Moduladores Seletivos de Receptor Estrogênico/síntese química , Moduladores Seletivos de Receptor Estrogênico/farmacologia , Estereoisomerismo , Útero/efeitos dos fármacos , Ensaios Antitumorais Modelo de Xenoenxerto
5.
J Virol Methods ; 258: 29-34, 2018 08.
Artigo em Inglês | MEDLINE | ID: mdl-29753708

RESUMO

The Potyvirus genus is one of the largest genera of plant viruses and encompasses many economically important pathogens. While a number of degenerate primers for use in broad spectrum RT-PCR assays have been published, it is not clear which of these primers would be the most useful for use by plant diagnostic laboratories. Twelve sets of primers were tested for their ability to detect nine potyviruses in a two-step RT-PCR. Viruses were extracted from different host backgrounds and were selected to represent eight clades plus one species between clades (sensu Gibbs and Ohshima, 2010). Results of this study indicated that the primers CIFor/CIRev produced easily detectable amplicons from all nine potyviruses without non-specific amplification, false positives, or false negatives. CIFor/CIRev produced single amplicons from potyvirus-infected tissues which could be sequenced directly without gel purification to identify the virus to species.


Assuntos
Primers do DNA/genética , Técnicas de Diagnóstico Molecular/métodos , Doenças das Plantas/virologia , Potyvirus/isolamento & purificação , Reação em Cadeia da Polimerase Via Transcriptase Reversa/métodos , Potyvirus/genética , Sensibilidade e Especificidade
6.
Pediatr Surg Int ; 33(11): 1167-1175, 2017 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-28875259

RESUMO

PURPOSE: To examine the effects of obesity on specialty-specific surgical outcomes in children. MATERIALS AND METHODS: Retrospective cohort study using the National Surgical Quality Improvement Program, Pediatric, 2012-2014. Patients included those aged 2-17 years who underwent a surgical procedure in one of six specialties. Obesity was the primary patient variable of interest. Outcomes of interest were postoperative complications and operative times. Odds ratios for development of postoperative complications were calculated using stepwise multivariate regression analysis. RESULTS: Obesity was associated with a significantly greater risk of wound complications (OR 1.24, 95% CI 1.13-1.36), but decreased risk of non-wound complications (OR 0.68, 95% CI 0.63-0.73) and morbidity (OR 0.79, 95% CI 0.75-0.84). Obesity was not a significant factor in predicting postoperative complications in patients undergoing otolaryngology or plastic surgery procedures. Anesthesia times and operative times were significantly longer for obese patients undergoing most types of pediatric surgical procedures. CONCLUSION: Obesity confers an increased risk of wound complications in some pediatric surgical specialties and is associated with overall decreased non-wound complications and morbidity. These findings suggest that the relationship between obesity and postoperative complications is complex and may be more dependent on underlying procedure- or specialty-related factors than previously suspected.


Assuntos
Índice de Massa Corporal , Obesidade/complicações , Procedimentos de Cirurgia Plástica , Complicações Pós-Operatórias/etiologia , Medição de Risco/métodos , Procedimentos Cirúrgicos Operatórios , Adolescente , Criança , Pré-Escolar , Feminino , Seguimentos , Humanos , Masculino , Morbidade/tendências , Razão de Chances , Duração da Cirurgia , Complicações Pós-Operatórias/epidemiologia , Estudos Retrospectivos , Fatores de Risco , Estados Unidos/epidemiologia
7.
Am J Transplant ; 16(3): 751-7, 2016 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-26690302

RESUMO

Natural killer (NK) cells are highly heterogeneous innate lymphocytes with a diverse repertoire of phenotypes and functions. Their role in organ transplantation has been poorly defined due to conflicting clinical and experimental data. There is evidence that NK cells can contribute to graft rejection and also to tolerance induction. In most solid organ transplantation settings, the role of NK cells is only considered from the perspective of the recipient immune system. In contrast to other organs, the liver contains major resident populations of immune cells, particularly enriched with innate lymphocytes such as NK cells, NKT cells, and gamma-delta T cells. Liver transplantation therefore results in a unique meeting of donor and recipient immune systems. The unusual immune repertoire and tolerogenic environment of the liver may explain why this potentially inflammatory "meeting" often results in attenuated immune responses and reduced requirement for immunosuppression. Recent trials of immunosuppression withdrawal in liver transplant patients have identified NK cell features as possible predictors of tolerance. Here we propose that hepatic NK cells play a key role in the induction of tolerance post-liver transplant and examine potential mechanisms by which these cells influence liver transplant outcome.


Assuntos
Imunidade Adaptativa/imunologia , Rejeição de Enxerto/imunologia , Tolerância Imunológica/imunologia , Células Matadoras Naturais/imunologia , Transplante de Fígado , Animais , Humanos
9.
Br J Cancer ; 112(7): 1199-205, 2015 Mar 31.
Artigo em Inglês | MEDLINE | ID: mdl-25756398

RESUMO

BACKGROUND: Sunitinib is approved worldwide for treatment of advanced pancreatic neuroendocrine tumours (pNET), but no validated markers exist to predict response. This analysis explored biomarkers associated with sunitinib activity and clinical benefit in patients with pNET and carcinoid tumours in a phase II study. METHODS: Plasma was assessed for vascular endothelial growth factor (VEGF)-A, soluble VEGF receptor (sVEGFR)-2, sVEGFR-3, interleukin (IL)-8 (n=105), and stromal cell-derived factor (SDF)-1α (n=28). Pre-treatment levels were compared between tumour types and correlated with response, progression-free (PFS), and overall survival (OS). Changes in circulating myelomonocytic and endothelial cells were also analysed. RESULTS: Stromal cell-derived factor-1α and sVEGFR-2 levels were higher in pNET than in carcinoid (P=0.003 and 0.041, respectively). High (above-median) baseline SDF-1α was associated with worse PFS, OS, and response in pNET, and high sVEGFR-2 with longer OS (P⩽0.05). For carcinoid, high IL-8, sVEGFR-3, and SDF-1α were associated with shorter PFS and OS, and high IL-8 and SDF-1α with worse response (P⩽0.05). Among circulating cell types, monocytes showed the largest on-treatment decrease, particularly CD14+ monocytes co-expressing VEGFR-1 or CXCR4. CONCLUSIONS: Interleukin-8, sVEGFR-3, and SDF-1α were identified as predictors of sunitinib clinical outcome. Putative pro-tumorigenic CXCR4+ and VEGFR-1+ monocytes represent novel candidate markers and biologically relevant targets explaining the activity of sunitinib.


Assuntos
Antineoplásicos/uso terapêutico , Biomarcadores Tumorais/sangue , Citocinas/sangue , Indóis/uso terapêutico , Monócitos/patologia , Tumores Neuroendócrinos/sangue , Tumores Neuroendócrinos/tratamento farmacológico , Pirróis/uso terapêutico , Biomarcadores Tumorais/imunologia , Tumor Carcinoide/sangue , Tumor Carcinoide/tratamento farmacológico , Tumor Carcinoide/imunologia , Citocinas/imunologia , Intervalo Livre de Doença , Feminino , Humanos , Contagem de Leucócitos , Monócitos/imunologia , Tumores Neuroendócrinos/imunologia , Sunitinibe , Resultado do Tratamento
10.
Ann Oncol ; 24(9): 2382-9, 2013 09.
Artigo em Inglês | MEDLINE | ID: mdl-23788751

RESUMO

BACKGROUND: Combined inhibition of vascular, platelet-derived, and epidermal growth factor receptor (EGFR) pathways may overcome refractoriness to single agents in platinum-pretreated non-small-cell lung cancer (NSCLC). PATIENTS AND METHODS: This randomized, double-blind, multicenter, phase II trial evaluated sunitinib 37.5 mg/day plus erlotinib 150 mg/day versus placebo plus erlotinib continuously in 4-week cycles. Eligible patients had histologically confirmed stage IIIB or IV NSCLC previously treated with one or two chemotherapy regimens, including one platinum-based regimen. The primary end point was progression-free survival (PFS) by an independent central review. RESULTS: One hundred and thirty-two patients were randomly assigned, and the median duration of follow-up was 17.7 months. The median PFS was 2.8 versus 2.0 months for the combination versus erlotinib alone (HR 0.898, P = 0.321). The median overall survival (OS) was 8.2 versus 7.6 months (HR 1.066, P = 0.617). Objective response rates (ORRs) were 4.6% and 3.0%, respectively. Sunitinib plus erlotinib was fairly well tolerated although most treatment-related adverse events (AEs) were more frequent than with erlotinib alone: diarrhea (55% versus 33%), rash (41% versus 30%), fatigue (31% versus 25%), decreased appetite (30% versus 13%), nausea (28% versus 14%), and thrombocytopenia (13% versus 0%). CONCLUSIONS: The addition of sunitinib to erlotinib did not significantly improve PFS in patients with advanced, platinum-pretreated NSCLC.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Carcinoma Pulmonar de Células não Pequenas/tratamento farmacológico , Indóis/uso terapêutico , Neoplasias Pulmonares/tratamento farmacológico , Pirróis/uso terapêutico , Quinazolinas/uso terapêutico , Adulto , Idoso , Inibidores da Angiogênese/efeitos adversos , Inibidores da Angiogênese/uso terapêutico , Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Carcinoma Pulmonar de Células não Pequenas/mortalidade , Intervalo Livre de Doença , Método Duplo-Cego , Receptores ErbB/antagonistas & inibidores , Cloridrato de Erlotinib , Feminino , Humanos , Indóis/efeitos adversos , Neoplasias Pulmonares/mortalidade , Masculino , Pessoa de Meia-Idade , Inibidores de Proteínas Quinases/efeitos adversos , Inibidores de Proteínas Quinases/uso terapêutico , Pirróis/efeitos adversos , Quinazolinas/efeitos adversos , Receptores do Fator de Crescimento Derivado de Plaquetas/antagonistas & inibidores , Receptores de Fatores de Crescimento do Endotélio Vascular/antagonistas & inibidores , Sunitinibe , Sobrevida , Resultado do Tratamento
11.
Phys Chem Chem Phys ; 15(16): 6068-79, 2013 Apr 28.
Artigo em Inglês | MEDLINE | ID: mdl-23493900

RESUMO

Evolution of electronic properties and the nature of bonding of the 4d-transition metal silicides (ZrSi, NbSi, MoSi and PdSi) are discussed, revealing interesting trends in the transition metal-silicon interactions across the period. The electronic properties of select transition metal silicide diatomics have been determined by anion photoelectron imaging spectroscopy and theoretical methods. The electron binding energy spectra and photoelectron angular distributions obtained by 2.33 eV (532 nm) photons have revealed the distinct features of these diatomics. The theoretical calculations were performed at the density functional theory (DFT) level using the unrestricted B3LYP hybrid functional and at the ab initio unrestricted coupled cluster singles and doubles (triplets) (UCCSD(T)) methods to assign the ground electronic states of the neutral and anionic diatomics. The excited electronic states were calculated by the DFT (TD-DFT)/UB3LYP method. We have observed that the valence molecular orbital configuration of the ZrSi and NbSi anions are significantly different from that of the MoSi and PdSi anions. By combining our experimental and theoretical results, we report that the composition of the highest occupied molecular orbitals shift from a majority of transition metal s- and d-orbital contribution in ZrSi and NbSi, to mainly silicon p-orbital contribution for MoSi and PdSi. We expect these observed atomic scale transition metal-silicon interactions to be of increasing importance with the miniaturization of devices approaching the sub-nanometer size regime.

12.
Plant Dis ; 97(10): 1378, 2013 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-30722174

RESUMO

Sentinel plots for monitoring Asian soybean rust (ASR) caused by Phakopsora pachyrhizi Syd. were initiated in 2005 at Isabela (EEI), Adjuntas (EEA), and Juana Diaz (EEJD) experiment stations. Until 2009, no signs or symptoms of ASR were observed in soybean (Glycine max [L.] Merr.) or common bean (Phaseolus vulgaris L.). These sites were found to be negative for the occurrence of ASR based on PCR with specific primers Ppa1 and Ppa2 (2). However, P. meibomiae, the cause of American soybean rust (AmSR) endemic to this region, was found in Adjuntas naturally infecting numerous wild and cultivated legumes, particularly Lablab purpureus (3). Symptoms of AmSR in L. purpureus appeared as reddish-brown spots on the underside of the leaves with three to four uredia per lesion. On February 12, 2011, leaf samples of soybean in beginning pod-fill (R5) and beginning-maturity (R8) growth stages were collected in a winter nursery at EEI and found to have small brown specks with chlorotic haloes on the underside of the leaves and leaf sections from symptomatic areas indicated an abundance of uredinia. Under the light microscope, urediniospores observed at 40× were morphologically similar to Phakopsora spp. Total DNA was extracted from leaf discs using the Qiagen DNeasy Plant Mini Kit following the methods of Frederick et al. (2). Detection of ASR pathogen was achieved via PCR amplification with Ppa1 and Ppa2 primers that are specific for P. pachyrhizi Syd. After sequencing the amplicon, BLAST analysis of the internal transcribed spacer (ITS) region of the ribosomal RNA genes indicated 100% identity with known P. pachyrhizi sequences in GenBank. The sequence of isolate P. pachyrhizi EEI-2011 was submitted to GenBank as JX994293. No amplification was observed after PCR with species-specific primers Pme1 and Pme2 specific for P. meibomiae (Arthur) Arthur. L. purpureus collected from EEA and Utuado only appears to be infected by P. meibomiae and no mixed infections with P. pachyrhizi were apparent, based on the PCR test. Leaf samples from EEI were sent to the UF Plant Diagnostic Center in Gainesville, FL, where quantitative PCR with primers Ppa1 and Ppa2 confirmed the presence of P. pachyrhizi; while P. meibomiae was not detected with primers Pme1 and Pme2. Pathogenicity tests were conducted on the soybean cv. Williams with isolate EEI-2011. Fifteen-day-old soybean plants were inoculated by attaching an infected and sporulating 1 cm2 piece of soybean leaf from EEI-2011 with an average of 4.5 × 105 urediniospores per cm2 (1). Inoculated plants were placed in a growth chamber at 20°C night and 28°C day temperatures, 80% humidity, and a 12-h light photoperiod. Small reddish brown spots with chlorotic haloes developed 4 to 6 days after inoculation and tan lesions appeared 10 to 15 days later. Mature tan lesions developed in 2 weeks with an average of 2.4 uredinia/lesion. Urediniospores were observed with light microscope and these were morphologically similar to those spores observed in the original diseased samples. Another PCR test confirmed P. pachyrhizi after amplification with the species-specific primers. The pathogenicity test was repeated twice with the same cultivar. To our knowledge, this is the first report of ASR in Puerto Rico and this finding will have implications as another overwintering site for Asian soybean rust in the Caribbean region. References: (1) C. Estévez de Jensen et al. J. Agric. Univ. P.R. 93:125, 2009. (2) R. D. Frederick et al. Phytopathology 92:217, 2002. (3) B. Vega and C. Estévez de Jensen. J. Agric. Univ. P.R. 94:211, 2010.

13.
J Chem Phys ; 136(21): 214314, 2012 Jun 07.
Artigo em Inglês | MEDLINE | ID: mdl-22697550

RESUMO

We report a combined experimental and theoretical photoelectron spectroscopy study of ZnOH(-). We find that the electron binding energy spectrum of ZnOH(-) reveals a broad and featureless peak between 1.4 and 2.4 eV in energy. The vertical detachment energy (VDE) of ZnOH(-) is determined to be 1.78 eV, which is lower than the 2.08 eV VDE of ZnO(-). Our theoretical calculations match the VDE of ZnOH(-) accurately, but we find that the broadness of the peak cannot be explained by rotational or vibrational state excitation. The broadness of this peak is in strong contrast to the narrow and easily understood first peak of the ZnO spectrum, which features a well-resolved vibrational progression that can be readily explained by calculating the Franck-Condon transition factors. This study provides spectroscopic evidence of the effect of hydrogen on diatomic ZnO.

14.
Phytopathology ; 102(7): 652-5, 2012 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22667444

RESUMO

Extension plant pathologists deliver science-based information that protects the economic value of agricultural and horticultural crops in the United States by educating growers and the general public about plant diseases. Extension plant pathologists diagnose plant diseases and disorders, provide advice, and conduct applied research on local and regional plant disease problems. During the last century, extension plant pathology programs have adjusted to demographic shifts in the U.S. population and to changes in program funding. Extension programs are now more collaborative and more specialized in response to a highly educated clientele. Changes in federal and state budgets and policies have also reduced funding and shifted the source of funding of extension plant pathologists from formula funds towards specialized competitive grants. These competitive grants often favor national over local and regional plant disease issues and typically require a long lead time to secure funding. These changes coupled with a reduction in personnel pose a threat to extension plant pathology programs. Increasing demand for high-quality, unbiased information and the continued reduction in local, state, and federal funds is unsustainable and, if not abated, will lead to a delay in response to emerging diseases, reduce crop yields, increase economic losses, and place U.S. agriculture at a global competitive disadvantage. In this letter, we outline four recommendations to strengthen the role and resources of extension plant pathologists as they guide our nation's food, feed, fuel, fiber, and ornamental producers into an era of increasing technological complexity and global competitiveness.


Assuntos
Patologia Vegetal/organização & administração , Relações Comunidade-Instituição , Doenças das Plantas , Estados Unidos
15.
Ann Oncol ; 23(3): 688-694, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-21821830

RESUMO

BACKGROUND: This phase 1/2 study assessed sunitinib combined with docetaxel (Taxotere) and prednisone in chemotherapy-naive metastatic, castration-resistant prostate cancer (mCRPC) patients. PATIENTS AND METHODS: To determine the recommended phase 2 dose (RP2D), 25 patients in four dose escalation cohorts received 3-week cycles of sunitinib (2 weeks on, 1 week off), docetaxel and prednisone, preceded by a 4-week sunitinib 50 mg/day lead in. RP2D was evaluated in 55 additional patients. The primary end point was prostate-specific antigen (PSA) response rate. RESULTS: One phase 1 dose-limiting toxicity occurred (grade 3 hyponatremia). The RP2D was sunitinib 37.5 mg/day, docetaxel 75 mg/m(2) and prednisone 5 mg b.i.d. During phase 2, confirmed PSA responses occurred in 31 patients [56.4% (95% confidence interval 42.3-69.7)]. Median time to PSA progression was 9.8 months. Forty-one patients (75%) were treated >3 months, 12 (22%) completed the study (16 cycles) and 43 (78%) discontinued (36% for disease progression and 27% adverse events). The most frequent treatment-related grade 3/4 adverse events were neutropenia (53%; 15% febrile) and fatigue/asthenia (16%). Among 33 assessable patients, 14 (42.4%) had confirmed partial response. Median progression-free and overall survivals were 12.6 and 21.7 months, respectively. CONCLUSION: This combination was moderately well tolerated, with promising response rate and survival benefit, justifying further investigation in mCRPC.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Recidiva Local de Neoplasia/tratamento farmacológico , Neoplasias da Próstata/tratamento farmacológico , Idoso , Idoso de 80 Anos ou mais , Intervalo Livre de Doença , Docetaxel , Resistencia a Medicamentos Antineoplásicos/efeitos dos fármacos , Humanos , Indóis/administração & dosagem , Indóis/efeitos adversos , Estimativa de Kaplan-Meier , Masculino , Dose Máxima Tolerável , Pessoa de Meia-Idade , Metástase Neoplásica/tratamento farmacológico , Recidiva Local de Neoplasia/mortalidade , Recidiva Local de Neoplasia/patologia , Prednisona/administração & dosagem , Prednisona/efeitos adversos , Antígeno Prostático Específico/sangue , Neoplasias da Próstata/mortalidade , Neoplasias da Próstata/patologia , Pirróis/administração & dosagem , Pirróis/efeitos adversos , Sunitinibe , Taxoides/administração & dosagem , Taxoides/efeitos adversos
16.
Plant Dis ; 95(4): 485-489, 2011 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-30743333

RESUMO

Field studies to quantify the effects of shade intensity and duration on soybean rust caused by Phakopsora pachyrhizi were carried out in Florida in 2006 and 2007. Soybean plants at the V4 stage were inoculated with urediniospores at 2100, 0000, and 0200 h. Inoculated plants were either placed in cages that were covered with shade cloths of different mesh sizes allowing 70, 50, or 20% transmission of sunlight or were not covered so that the plants received 100% of sunlight. Plants kept under 20 and 100% sunlight were sampled 12, 18, and 36 h after inoculation to determine the in vivo germination percentage of urediniospores and the percentage of germ tubes that formed appressoria. In separate experiments, inoculated plants were placed under the shade (20% sunlight) and moved to unshaded conditions after 1, 2, and 7 days. For all experiments, soybean rust incidence and severity were rated 12 days after inoculation. Higher levels of disease incidence and severity were detected in plants under shade compared with those under full sunlight. Shade duration greater than 2 days favored disease development. Within 36 h, in vivo germination of urediniospores and formation of appressoria were not significantly affected by the treatments. These results may explain why soybean rust is more severe in the lower canopy and shaded areas in the field.

17.
Eur J Cancer ; 45(11): 1959-68, 2009 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-19282169

RESUMO

AIMS: To assess the antitumour activity, safety, pharmacokinetics and pharmacodynamics of continuous daily sunitinib dosing in patients with imatinib-resistant/intolerant gastrointestinal stromal tumour (GIST) and to assess morning dosing versus evening dosing. PATIENTS AND METHODS: In this open-label phase II study, patients were randomised to receive morning or evening dosing of sunitinib 37.5mg/day. The primary end-point was clinical benefit rate (CBR; percent complete responses+partial responses [PRs]+stable disease [SD] 24 weeks). Secondary end-points included progression-free survival (PFS), overall survival (OS), safety, pharmacokinetic parameters and plasma biomarker levels. RESULTS: Sixty of 61 planned patients received treatment (30 per dosing group); 26 completed the study. Overall, the CBR was 53% (95% exact CI, 40-66): eight patients (13%) achieved objective PRs; 24 (40%) achieved SD 24 weeks. Median PFS was 34 weeks (95% CI, 24-49); median OS was 107 weeks (95% CI, 72 - not yet calculable). Most adverse events (AEs) were of grade 1 or 2 in severity, and were manageable through dose modification or standard interventions. No new AEs were apparent compared with the approved intermittent dosing schedule. Antitumour activity and safety were generally similar with morning and evening dosing. Continuous daily sunitinib dosing achieved and sustained effective drug concentrations without additional accumulation across cycles. Decreases from baseline in plasma levels of soluble KIT after 20 and 24 weeks of dosing correlated with longer OS. CONCLUSION: For patients with imatinib-resistant/intolerant GIST, continuous daily sunitinib dosing appears to be an active alternative dosing strategy with acceptable safety.


Assuntos
Inibidores da Angiogênese/uso terapêutico , Tumores do Estroma Gastrointestinal/tratamento farmacológico , Indóis/uso terapêutico , Pirróis/uso terapêutico , Adulto , Idoso , Idoso de 80 Anos ou mais , Inibidores da Angiogênese/sangue , Inibidores da Angiogênese/farmacocinética , Benzamidas , Biomarcadores Tumorais/sangue , Intervalo Livre de Doença , Esquema de Medicação , Resistencia a Medicamentos Antineoplásicos , Feminino , Tumores do Estroma Gastrointestinal/sangue , Tumores do Estroma Gastrointestinal/mortalidade , Humanos , Mesilato de Imatinib , Indóis/sangue , Indóis/farmacocinética , Masculino , Pessoa de Meia-Idade , Piperazinas/uso terapêutico , Proteínas Proto-Oncogênicas c-kit/sangue , Pirimidinas/uso terapêutico , Pirróis/sangue , Pirróis/farmacocinética , Sunitinibe , Taxa de Sobrevida , Resultado do Tratamento , Fator A de Crescimento do Endotélio Vascular/sangue , Receptor 2 de Fatores de Crescimento do Endotélio Vascular/sangue , Receptor 3 de Fatores de Crescimento do Endotélio Vascular/sangue
18.
Plant Dis ; 92(10): 1472, 2008 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-30769555

RESUMO

Soybean rust (SBR), caused by the obligate fungus Phakopsora pachyrhizi Syd. & P. Syd., was initially reported on soybean (Glycine max L.) in Louisiana in 2004 and has since been reported on soybean and/or kudzu (Pueraria lobata (Willd.) Ohwi) in 9 states in 2005, 15 states in 2006, and 19 states in 2007 (1). The host range of P. pachyrhizi includes plants that are all in the Fabaceae or legume family. Six plant species in the United States have been reported as hosts of P. pachyrhizi: soybean, kudzu, Florida beggarweed (Desmodium tortuosum (Sw) DC.), dry bean (Phaseolus vulgaris L.), lima bean (P. lunatus L.), and scarlet runner bean (P. coccineus L.) (4). On 17 April 2008, a rust disease was observed on a weedy legume host with red showy flowers that was growing with kudzu in an overgrown vacant lot in the understory of live oak trees (Quercus virginiana Mill.) in Citra, FL. The discovery was made during routine scouting of this Integrated Pest Management Pest Information Platform for Extension and Education (IPM PIPE) mobile sentinel plot (3). The plant was confirmed by University of Florida botanists to be Erythrina herbaceae L., commonly known as coral bean. Coral bean is native to the southeastern United States and also is planted as a perennial ornamental. A sample of leaves exhibiting rust pustules characteristic of P. pachyrhizi uredinia was collected and examined with a microscope. Brown-to-brick red, angular lesions that were 3 to 11 mm in diameter (average 6.75 mm) were observed on the undersides of the leaves of two trifoliates. Within these lesions, there were several uredinia, some exuding hyaline, echinulate urediniospores (20 × 25 µm). The visual diagnosis and the species of the rust fungus were confirmed to be P. pachyrizi by a real-time PCR protocol (2). The diagnosis on this new host was verified by a USDA, APHIS National Mycologist in Beltsville, MD. Coral bean may serve as an additional overwintering host for P. pachyrhizi in the southeast. To our knowledge, this is the first report of soybean rust caused by P. pachyrhizi on E. herbaceae. References: (1) R. S. C. Christiano and H. Scherm, Phytopathology 97:1428, 2007. (2) R. D. Frederick et al. Phytopathology 92:217, 2002. (3) S. A. Isard et al. Online publication. doi:10.1094/PHP-2006-0915-01-RV. Plant Health Progress, 2006. (4) T. L. Slaminko et al. Plant Dis. 92:767, 2008.

19.
Surg Endosc ; 20(7): 1051-4, 2006 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-16736313

RESUMO

BACKGROUND: The role of laparoscopic appendectomy for perforated appendicitis remains controversial. This study aimed to compare laparoscopic and open appendectomy outcomes for children with perforated appendicitis. METHODS: Over a 36-month period, 111 children with perforated appendicitis were analyzed in a retrospective review. These children were treated with either laparoscopic (n = 59) or open appendectomy. The primary outcome measures were operative time, length of hospital stay, time to adequate oral intake, wound infection, intraabdominal abscess formation, and bowel obstruction. RESULTS: The demographic data, presenting symptoms, preoperative laboratory values, and operative times (laparoscopic group, 61 +/- 3 min; open group, 57 +/- 3 were similar for the two groups (p = 0.3). The time to adequate oral intake was 104 +/- 7 h for the laparoscopic group and 127 +/- 12 h for the open group (p = 0.08). The hospitalization time was 189 +/- 14 h for the laparoscopic group, as compared with 210 +/- 15 h for the open group (p = 0.3). The wound infection rate was 6.8% for the laparoscopic group and 23% for the open group (p < 0.05). The wounds of another 29% of the patients were left open at the time of surgery. The postoperative intraabdominal abscess formation rate was 13.6% for the laparoscopic group and 15.4% for the open group. One patient in each group experienced bowel obstruction. CONCLUSIONS: Laparoscopic appendectomy for the children with perforated appendicitis in this study was associated with a significant decrease in the rate of wound infection. Furthermore, on the average, the children who underwent laparoscopic appendectomy tolerated enteral feedings and were discharged from the hospital approximately 24 h earlier than those who had open appendectomy.


Assuntos
Apendicectomia/métodos , Apendicite/cirurgia , Laparoscopia , Apendicectomia/efeitos adversos , Criança , Feminino , Humanos , Laparoscopia/efeitos adversos , Masculino , Complicações Pós-Operatórias/epidemiologia , Complicações Pós-Operatórias/etiologia , Estudos Retrospectivos
20.
Surg Endosc ; 20(4): 624-7, 2006 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-16508814

RESUMO

BACKGROUND: Antegrade colonic enemas offer a surgical solution for many children with chronic constipation and encopresis associated with Hirschsprung's disease and anorectal malformations. This study demonstrated the feasibility of a new laparoscopic technique for cecostomy button placement (LCBP) to allow antegrade enema treatment. METHODS: Charts of children with encopresis who underwent LCBP between 1999 and 2001 were reviewed. The age, weight, primary diagnosis, operative time, hospital stay, associated complications, follow-up duration, and outcome of the patients were recorded. The surgical technique used a "U-stitch" method and a chait tube or a standard gastrostomy button. A follow-up telephone survey was conducted to assess parental satisfaction and overall success in continence. RESULTS: Seven patients ages 4 to 12 years (mean, 7.3 +/- 1.3 years) and weighing 15 to 44 kg (mean, 24.5 +/- 4 kg) underwent LCBP over a 2-year period. The mean follow-up period was 15 +/- 4 months (range, 6-33 months). Four patients had anorectal malformations, and three patients had Hirschsprung's disease. For all the patients, LCBP was accomplished without any intraoperative complications. The mean operative time was 33 +/- 2 min, and the hospital stay was 2 to 5 days (mean, 3.8 +/- 0.5 days). The patients received one or two daily antegrade enemas, and none had accidental bowel movements. Episodes of soiling at night once or twice a week were observed with two children. Two patients had hypertrophic granulation tissue formation, which responded to topical therapy. The button was uneventfully changed twice in one patient because of mechanical malfunction. CONCLUSION: To manage overflow incontinence of children with anorectal malformations and Hirschsprung's disease, LCBP is a technically straightforward, effective, and reversible method for the placement of a cecostomy button.


Assuntos
Canal Anal/anormalidades , Cecostomia/métodos , Incontinência Fecal/cirurgia , Doença de Hirschsprung/complicações , Laparoscopia , Próteses e Implantes , Reto/anormalidades , Cecostomia/efeitos adversos , Criança , Pré-Escolar , Anormalidades do Sistema Digestório/complicações , Enema/métodos , Desenho de Equipamento , Estudos de Viabilidade , Incontinência Fecal/etiologia , Incontinência Fecal/terapia , Feminino , Humanos , Masculino , Cuidados Pós-Operatórios , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...